Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ullrich

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery and Characterization of Zilurgisertib, a Potent and Selective Inhibitor of Activin Receptor-like Kinase‑2 (ALK2) for the Treatment of Fibrodysplasia Ossificans ProgressivaThomas Ullrich, Sabine Guth, Luca Arista, et al.
Psychopharmacology|January 24, 2004
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in miceWilliam E Fantegrossi, Christina Lynn Kiessel, P Tarn Leach, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Multifunctional Carrier Based on Halloysite/Laponite Hybrid Hydrogel for Kartogenin DeliveryMarina Massaro, Gabriella Buscemi, Luca Arista, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamideIn Jong Kim, Thomas Ullrich, James W Janetka, et al.
Advanced Drug Delivery Reviews|November 17, 2020
Clinically established biodegradable long acting injectables: An industry perspectiveChristian Isalomboto Nkanga, Andreas Fisch, Mazda Rad-Malekshahi, et al.
Nature Biomedical Engineering|January 4, 2022
Enhanced tendon healing by a tough hydrogel with an adhesive side and high drug-loading capacityBenjamin R Freedman, Andreas Kuttler, Nicolau Beckmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2019
Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived <i>β</i> <sub>2</sub>-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical StudiesMagdalena Koziczak-Holbro, Dean F Rigel, Bérengère Dumotier, et al.
Journal of Medicinal Chemistry|August 15, 2014
3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administrationThomas Ullrich, Sanjita Sasmal, Venkatesham Boorgu, et al.
Journal of Medicinal Chemistry|November 22, 2024
Identification of TAK-756, A Potent TAK1 Inhibitor for the Treatment of Osteoarthritis through Intra-Articular AdministrationJean-Baptiste Langlois, Silke Brenneisen, Stephane Rodde, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery and Characterization of Zilurgisertib, a Potent and Selective Inhibitor of Activin Receptor-like Kinase‑2 (ALK2) for the Treatment of Fibrodysplasia Ossificans ProgressivaThomas Ullrich, Sabine Guth, Luca Arista, et al.
Psychopharmacology|January 24, 2004
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in miceWilliam E Fantegrossi, Christina Lynn Kiessel, P Tarn Leach, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Multifunctional Carrier Based on Halloysite/Laponite Hybrid Hydrogel for Kartogenin DeliveryMarina Massaro, Gabriella Buscemi, Luca Arista, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamideIn Jong Kim, Thomas Ullrich, James W Janetka, et al.
Advanced Drug Delivery Reviews|November 17, 2020
Clinically established biodegradable long acting injectables: An industry perspectiveChristian Isalomboto Nkanga, Andreas Fisch, Mazda Rad-Malekshahi, et al.
Nature Biomedical Engineering|January 4, 2022
Enhanced tendon healing by a tough hydrogel with an adhesive side and high drug-loading capacityBenjamin R Freedman, Andreas Kuttler, Nicolau Beckmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2019
Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived <i>β</i> <sub>2</sub>-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical StudiesMagdalena Koziczak-Holbro, Dean F Rigel, Bérengère Dumotier, et al.
Journal of Medicinal Chemistry|August 15, 2014
3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administrationThomas Ullrich, Sanjita Sasmal, Venkatesham Boorgu, et al.
Journal of Medicinal Chemistry|November 22, 2024
Identification of TAK-756, A Potent TAK1 Inhibitor for the Treatment of Osteoarthritis through Intra-Articular AdministrationJean-Baptiste Langlois, Silke Brenneisen, Stephane Rodde, et al.
Pageof 3